Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Further to our earlier intimation dated August 6, 2026, pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that a meeting of the Board of Directors of the Company will be held on August 14, 2026 to consider and evaluate proposals for raising funds through issuance of equity shares or other securities, including by way of a public issue, preferential issue, rights issue, private placement(s), qualified institutions placement(s) and/or any combination thereof or any other method as may be permitted in accordance with provisions of applicable laws, subject to market conditions and receipt of regulatory, statutory and other approvals as may be required